FDA inspects registered drug establishments for current Good Manufacturing Practice and other requirements. An inspection may be pre-approval, routine surveillance, or for-cause and covers a defined project area.
The public record includes the end date, project area, and outcome: no action indicated (NAI), voluntary action indicated (VAI), or official action indicated (OAI). Read each outcome with its scope and any later follow-up; it is not a grade for the entire facility.
Educational reference · not legal or regulatory advice.